[Clinical practice guideline for the prevention and management of acute kidney injury in the Social Security of Health of Peru (EsSalud)]

Authors

  • Antonio Manuel Fernández Burga Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Perú.
  • Lesly Chávez-Rimache Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú; Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Perú
  • Rosa Luz López Martínez Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Perú.
  • María Susana Picón Pérez Hospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Lima, Perú.
  • Katiuska Carpio Aguilar Hospital I Victor Alfredo Lazo Peralta, EsSalud, Madre de Dios, Perú.
  • Cesar Eduardo Cruzalegui Gómez Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
  • Pedro Antonio Mayma Martínez Hospital Nacional Alberto Sabogal Sologuren, EsSalud, Lima, Perú.
  • Julio César Arica Palomino Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.
  • Milagros del Pilar Dapello Jiménez Hospital Nacional Alberto Sabogal Sologuren, EsSalud, Lima, Perú.
  • Amilkar David Anticona Camayoc Hospital II de EsSalud Pasco, Pasco, Perú.
  • Luis Enrique Cruz Llanos Instituto Nacional Cardiovascular, EsSalud, Lima, Perú.
  • Wendy Nieto-Gutiérrez Universidad Científica del Sur, Lima, Perú.
  • Naysha Becerra-Chauca Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.
  • Ana Brañez-Condorena Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.
  • Jhonatan R Mejía Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.
  • Jorge Huaringa-Marcelo Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.
  • Alvaro Taype-Rondan Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú; Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Perú.
  • Stefany Salvador-Salvador Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.
  • Vladimir Santos-Sánchez Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

DOI:

https://doi.org/10.35434/rcmhnaaa.2024.171.1967

Keywords:

Acute Kidney Injury, GRADE, Evidence-Based Medicine, Clinical practice guidelines

Abstract

Introduction: This article summarizes the clinical practice guideline (CPG) for the prevention and management of acute kidney injury in the Social Security of Peru (EsSalud). Objective: Provide clinical recommendations based on evidence for the prevention and management of acute kidney injury in EsSalud. Methods: A guideline development group (GEG) was formed that included medical specialists and methodologists. The GEG formulated 6 clinical questions to be answered by this CPG. Systematic searches of systematic reviews and -when considered relevant- primary studies were carried out in PubMed during 2022. Evidence was selected to answer each of the clinical questions posed. The certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology. In regular work meetings, the GEG used the GRADE methodology to review the evidence and formulate the recommendations, the points of good clinical practice, and the corresponding flowcharts. Finally, the CPG was approved with Resolution No. 099-IETSI-ESSALUD-2022. Results: This CPG addressed 6 clinical questions on prevention, diagnosis and management (fluid therapy). Based on these questions, 5 recommendations (3 strong and 2 conditional), 2 BPCs, and 2 flowcharts were formulated. Conclusion: This article summarizes the methodology and evidence-based conclusions of the CPG for the prevention and management of acute kidney injury in EsSalud.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Antonio Manuel Fernández Burga, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Perú.

1. Especialista en Nefrología

Lesly Chávez-Rimache, Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú; Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Perú

1. Cirujana Dentista 

Rosa Luz López Martínez, Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima, Perú.

1. Especialista en Medicina Intensiva 

María Susana Picón Pérez, Hospital Nacional Almanzor Aguinaga Asenjo, EsSalud, Lima, Perú.

1. Especialista en Nefrología

Katiuska Carpio Aguilar, Hospital I Victor Alfredo Lazo Peralta, EsSalud, Madre de Dios, Perú.

1. Especialista en Medicina Interna  

Cesar Eduardo Cruzalegui Gómez, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.

1. Especialista en Nefrología

Pedro Antonio Mayma Martínez, Hospital Nacional Alberto Sabogal Sologuren, EsSalud, Lima, Perú.

1. Especialista en Medicina Intensiva

Julio César Arica Palomino, Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú.

1. Especialista en Medicina Interna 

Milagros del Pilar Dapello Jiménez, Hospital Nacional Alberto Sabogal Sologuren, EsSalud, Lima, Perú.

1. Especialista en Nefrología

Amilkar David Anticona Camayoc, Hospital II de EsSalud Pasco, Pasco, Perú.

1. Especialista en Medicina Interna  

Luis Enrique Cruz Llanos, Instituto Nacional Cardiovascular, EsSalud, Lima, Perú.

1. Especialista en Nefrología

Wendy Nieto-Gutiérrez, Universidad Científica del Sur, Lima, Perú.

1. Médico Cirujano  

Naysha Becerra-Chauca, Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

1. Licenciada en Obstetricia  

Ana Brañez-Condorena, Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

1. Médico Cirujano  

Jhonatan R Mejía , Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

1. Médico Cirujano  

Jorge Huaringa-Marcelo, Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

1. Especialista en Medicina Interna  

Alvaro Taype-Rondan, Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú; Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Perú.

1. Maestro en Ciencias en Investigación Epidemiológica

Stefany Salvador-Salvador, Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

1. Licenciada en Obstetricia  

Vladimir Santos-Sánchez , Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Perú.

1. Médico Cirujano especialista en Gerencia en Salud

References

Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice. 2012;120(4):c179-c84. doi: 10.1159/000339789.

Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482-93. doi: 10.2215/CJN.00710113.

Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. bmj. 2017;358:j4008. doi: 10.1136/bmj.j4008.

Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of clinical epidemiology. 2011;64(4):401-6. doi: 10.1016/j.jclinepi.2010.07.015.

Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. bmj. 2016;353:i2016. doi: 10.1136/bmj.i2016.

Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. bmj. 2016;353:i2089. doi: 10.1136/bmj.i2089.

Rabar S, Lau R, O'Flynn N, Li L, Barry P. Risk assessment of fragility fractures: summary of NICE guidance. Bmj. 2012;345:e3698. doi: 10.1136/bmj.e3698.

National Institute for Health and Care Excellence. Acute kidney injury: prevention, detection and management. London: National Institute for Health and Care Excellence; 2019.

Hodgson LE, Sarnowski A, Roderick PJ, Dimitrov BD, Venn RM, Forni LG. Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations. BMJ Open. 2017;7(9):e016591. doi: 10.1136/bmjopen-2017-016591.

Doi K, Nishida O, Shigematsu T, Sadahiro T, Itami N, Iseki K, et al. The Japanese Clinical Practice Guideline for acute kidney injury 2016. Journal of Intensive Care. 2018;6(1):48. doi: 10.1007/s10157-018-1600-4.

Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14(5):R185. doi: 10.1186/cc9293.

Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. New England Journal of Medicine. 2018;378(9):829-39. doi: 10.1056/NEJMoa1711584.

Zwager CL, Tuinman PR, de Grooth H-J, Kooter J, Ket H, Fleuren LM, et al. Why physiology will continue to guide the choice between balanced crystalloids and normal saline: a systematic review and meta-analysis. Critical Care. 2019;23(1):366. doi: 10.1186/s13054-019-2658-4.

Dong WH, Yan WQ, Song X, Zhou WQ, Chen Z. Fluid resuscitation with balanced crystalloids versus normal saline in critically ill patients: a systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2022;30(1):28. doi: 10.1186/s13049-022-01015-3.

Rein JL, Coca SG. "I don't get no respect": the role of chloride in acute kidney injury. American journal of physiology Renal physiology. 2019;316(3):F587-f605. doi: 10.1152/ajprenal.00130.2018.

Schiffl H. Sodium bicarbonate infusion for prevention of acute kidney injury: no evidence for superior benefit, but risk for harm? International urology and nephrology. 2015;47(2):321-6. doi: 10.1007/s11255-014-0820-0.

Zhao J, Li M, Tan C. Efficacy of N-acetylcysteine in Preventing Acute Kidney Injury and Major Adverse Cardiac Events After Cardiac Surgery: A Meta-Analysis and Trial Sequential Analysis. Frontiers in medicine. 2022;9:795839. doi: 10.3389/fmed.2022.795839.

Jang JS, Jin HY, Seo JS, Yang TH, Kim DK, Kim TH, Urm SH, Kim DS, Kim DK, Seol SH, Kim DI, Cho KI, Kim BH, Park YH, Je HG, Ahn JM, Kim WJ, Lee JY, Lee SW. Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury – a systematic review and meta-analysis –. Circ J. 2012;76(9):2255-65. doi: 10.1253/circj.cj-12-0096. 19. Sharp AJ, Patel N, Reeves BC, Angelini GD, Fiorentino F. Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials. Open heart. 2019;6(1):e000864.

Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204-12. doi: 10.1186/cc2872.

Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi: 10.1186/cc5713.

International Society of Nephrology. KDIGO Clinical Practice Guideline for Acute Kidney Injury. In: ISN, editor.: ISN; 2012.

Fujii T, Uchino S, Takinami M, Bellomo R. Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol. 2014;9(5):848-54. doi: 10.2215/CJN.09530913.

Zeng X, McMahon GM, Brunelli SM, Bates DW, Waikar SS. Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol. 2014;9(1):12-20. doi: 10.2215/CJN.02730313.

Huang ZY, Liu Y, Huang HF, Huang SH, Wang JX, Tian JF, et al. Acute kidney injury in traumatic brain injury intensive care unit patients. World J Clin Cases. 2022;10(9):2751-63. doi: 10.12998/wjcc.v10.i9.2751.

Avgerinos I, Michailidis T, Liakos A, Karagiannis T, Matthews DR, Tsapas A, et al. Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism. 2020;22(3):335-45. doi: 10.1111/dom.13899.

Pereira M, Rodrigues N, Godinho I, Gameiro J, Neves M, Gouveia J, et al. Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the 'Risk, Injury, Failure, Loss of kidney function, End-stage kidney disease' (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease: Improving Global Outcomes (KDIGO) classifications. Clin Kidney J. 2017;10(3):332-40. doi: 10.1093/ckj/sfw107.

Zhou J, Liu Y, Tang Y, Liu F, Zhang L, Zeng X, et al. A comparison of RIFLE, AKIN, KDIGO, and Cys-C criteria for the definition of acute kidney injury in critically ill patients. Int Urol Nephrol. 2016;48(1):125-32. doi: 10.1007/s11255-015-1150-6.

Rodrigo E, Suberviola B, Albines Z, Castellanos Á, Heras M, Rodriguez-Borregán JC, et al. Comparación de los sistemas de clasificación del fracaso renal agudo en la sepsis. Nefrología (Madrid). 2016;36:530-4. doi: 10.1016/j.nefro.2016.03.021.

Shinjo H, Sato W, Imai E, Kosugi T, Hayashi H, Nishimura K, et al. Comparison of kidney disease: improving global outcomes and acute kidney injury network criteria for assessing patients in intensive care units. Clin Exp Nephrol. 2014;18(5):737-45. doi: 10.1007/s10157-013-0915-4.

Bagshaw SM, Gibney RT. Conventional markers of kidney function. Crit Care Med. 2008;36(4 Suppl):S152-8. doi: 10.1097/CCM.0b013e318168c613.

Bove T, Belletti A, Putzu A, Pappacena S, Denaro G, Landoni G, Bagshaw SM, Zangrillo A. Intermittent furosemide administration in patients with or at risk for acute kidney injury: Meta-analysis of randomized trials. PLoS One. 2018 Apr 24;13(4):e0196088. doi: 10.1371/journal.pone.0196088.

Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010 Mar;65(3):283-93. doi: 10.1111/j.1365-2044.2009.06228.x.

Krzych ŁJ, Czempik PF. Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials. Ann Intensive Care. 2019 Jul 24;9(1):85. doi: 10.1186/s13613-019-0557-0.

Bhatt GC, Das RR. Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review & meta-analysis of randomized controlled trials. BMC Nephrol. 2017 Feb 28;18(1):78. doi: 10.1186/s12882-017-0486-9.

Bhatt GC, Das RR, Satapathy A. Early versus Late Initiation of Renal Replacement Therapy: Have We Reached the Consensus? An Updated Meta-Analysis. Nephron. 2021;145(4):371-385. doi: 10.1159/000515129.

Chen JJ, Lee CC, Kuo G, Fan PC, Lin CY, Chang SW, Tian YC, Chen YC, Chang CH. Comparison between watchful waiting strategy and early initiation of renal replacement therapy in the critically ill acute kidney injury population: an updated systematic review and meta-analysis. Ann Intensive Care. 2020 Mar 3;10(1):30. doi: 10.1186/s13613-020-0641-5..

Li Y, Li H, Zhang D. Timing of continuous renal replacement therapy in patients with septic AKI: A systematic review and meta-analysis. Medicine (Baltimore). 2019 Aug;98(33):e16800. doi: 10.1097/MD.0000000000016800.

Gaudry S, Hajage D, Benichou N, Chaïbi K, Barbar S, Zarbock A, Lumlertgul N, Wald R, Bagshaw SM, Srisawat N, Combes A, Geri G, Jamale T, Dechartres A, Quenot JP, Dreyfuss D. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020 May 9;395(10235):1506-1515. doi: 10.1016/S0140-6736(20)30531-6.

Pan HC, Chen YY, Tsai IJ, Shiao CC, Huang TM, Chan CK, Liao HW, Lai TS, Chueh Y, Wu VC, Chen YM. Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury: a systematic review and meta-analysis of RCT studies. Crit Care. 2021 Jan 5;25(1):5. doi: 10.1186/s13054-020-03434-z.

Lin WT, Lai CC, Chang SP, Wang JJ. Effects of early dialysis on the outcomes of critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials. Sci Rep. 2019 Dec 4;9(1):18283. doi: 10.1038/s41598-019-54777-9.

Andonovic M, Shemilt R, Sim M, Traynor JP, Shaw M, Mark PB, Puxty KA. Timing of renal replacement therapy for patients with acute kidney injury: A systematic review and metaanalysis. J Intensive Care Soc. 2021 Feb;22(1):67-77. doi: 10.1177/1751143720901688.

Published

2024-04-07

How to Cite

1.
Fernández Burga AM, Chávez-Rimache L, López Martínez RL, Picón Pérez MS, Carpio Aguilar K, Cruzalegui Gómez CE, Mayma Martínez PA, Arica Palomino JC, Dapello Jiménez M del P, Anticona Camayoc AD, Cruz Llanos LE, Nieto-Gutiérrez W, Becerra-Chauca N, Brañez-Condorena A, R Mejía J, Huaringa-Marcelo J, Taype-Rondan A, Salvador-Salvador S, Santos-Sánchez V. [Clinical practice guideline for the prevention and management of acute kidney injury in the Social Security of Health of Peru (EsSalud)]. Rev. Cuerpo Med. HNAAA [Internet]. 2024 Apr. 7 [cited 2024 Nov. 24];17(1). Available from: http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1967

Recommended Articles

1 2 3 4 > >>